{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:10:11Z","timestamp":1758579011049,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.transproceed.2021.02.010","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T19:15:37Z","timestamp":1615403737000},"page":"1292-1294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anaphylaxis Induced by Intravenous Tacrolimus Administration During Kidney Transplant Surgery: A Case Report"],"prefix":"10.1016","volume":"53","author":[{"given":"Ryohei","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichiro","family":"Sagehashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketoshi","family":"Nara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Numakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Habuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.02.010_bib0001","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0002","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0003","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.anai.2010.01.023","article-title":"World Allergy Organization: World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings","volume":"104","author":"Simons","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1081-1206(10)62234-X","article-title":"IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine","volume":"87","author":"Ebo","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5415\/apallergy.2015.5.3.181","article-title":"Intravenous tacrolimus and cyclosporine induced anaphylaxis: what is next?","volume":"5","author":"Kang","year":"2015","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0006","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bmt.1703161","article-title":"Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient","volume":"28","author":"Takamatsu","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0007","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/TP.0b013e31826e5995","article-title":"Hypersensitivity reaction to intravenous but not oral tacrolimus","volume":"94","author":"Nicolai","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0008","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/1078155219869442","article-title":"Successful switch to oral tacrolimus in a patient with hypersensitivity reaction to parenteral vitamin K, cyclosporine, and tacrolimus: a case report","volume":"26","author":"Taghvaye-Masoumi","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","article-title":"Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation","volume":"28","author":"Hiraoka","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0010","first-page":"885","article-title":"FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and\/or other immunosuppressants. Japanese FK506 BMT Study Group","volume":"15","author":"Kanamaru","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0011","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.bbmt.2016.02.005","article-title":"Risk factors for subtherapeutic tacrolimus levels after conversion from continuous intravenous infusion to oral in children after allogeneic hematopoietic cell transplantation","volume":"22","author":"Kolb","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0012","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bmt.1701331","article-title":"Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation","volume":"22","author":"Jacobson","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.02.010_bib0013","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1177\/106002809703101120","article-title":"Methods for preventing reactions secondary to Cremophor EL","volume":"31","author":"Michaud","year":"1997","journal-title":"Ann Pharmacother"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521001214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521001214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:39:11Z","timestamp":1758577151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521001214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0041134521001214"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.02.010","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anaphylaxis Induced by Intravenous Tacrolimus Administration During Kidney Transplant Surgery: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}